Biotech raises $42 million to run Huntington’s disease trial
Allison DeAngelis is an East Coast biotechnology and venture reporter at STAT, where science ideas and money collide. She is also co-host of the weekly biotechnology podcast, The Readout Loud. You can reach Allison on Signal at AllisonDeAngelis.01. Gene therapy startup Latus Bio has raised another $42 million to launch its first clinical trials, in […]